Tilray Brands (TLRY) Operating Leases (2019 - 2026)
Tilray Brands' (TLRY) quarterly Operating Leases came in at $158.2 million in Q2 2026, up 143.6% YoY from $64.9 million in Q2 2025, and up 162.36% on a QoQ basis from $60.3 million in Q1 2026.
Tilray Brands (TLRY) Operating Leases (2019 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 8 years of Operating Leases data on file, last reported at $158.2 million in Q2 2026.
- Quarterly Operating Leases rose 143.6% year-over-year to $158.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $158.2 million (up 143.6% YoY) and the FY2026 annual result came in at $158.2 million, up 143.6% from the prior year.
- Operating Leases rose to $158.2 million in Q2 2026, from $60.3 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $158.2 million in Q2 2026 to a low of $7.5 million in Q3 2023.
- A 5-year average of $47.3 million and a median of $60.4 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases slumped 82.04% — and 2024, when it soared 751.69%.
- Tracing TLRY's Operating Leases over 5 years: stood at $9.0 million in 2022, then jumped by 677.58% to $70.0 million in 2023, then slipped by 11.36% to $62.0 million in 2024, then declined by 0.45% to $61.7 million in 2025, then soared by 156.15% to $158.2 million in 2026.
- The last three Operating Leases figures came in at $158.2 million (Q2 2026), $60.3 million (Q1 2026), and $61.7 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 158.16 Mn |
| Feb 28, 2026 | 60.28 Mn |
| Nov 30, 2025 | 61.74 Mn |
| Aug 31, 2025 | 63.35 Mn |
| May 31, 2025 | 64.93 Mn |
| Nov 30, 2024 | 62.02 Mn |
| Aug 31, 2024 | 60.66 Mn |
| May 31, 2024 | 60.42 Mn |
| Feb 29, 2024 | 73.23 Mn |
| Nov 30, 2023 | 69.97 Mn |
| Aug 31, 2023 | 7.46 Mn |
| May 31, 2023 | 7.94 Mn |
| Feb 28, 2023 | 8.60 Mn |
| Nov 30, 2022 | 9.00 Mn |
| Aug 31, 2022 | 9.58 Mn |
| May 31, 2022 | 11.33 Mn |
| Feb 28, 2022 | 16.21 Mn |
| Nov 30, 2021 | 49.27 Mn |
| Aug 31, 2021 | 53.33 Mn |
| May 31, 2021 | 53.95 Mn |